NCT05355337View on ClinicalTrials.gov

Pramipexole for Anhedonic Depression

PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

February 8, 2023

Primary Completion Date

June 4, 2025

Study Completion Date

September 30, 2025

Conditions

Psychiatric Disorders MoodAnhedoniaDepression

Interventions

DRUG

Pramipexole

9 weeks of treatment with Pramipexole

DRUG

Placebo

9 weeks of treatment with Placebo

Trial Locations (1)

221 85

Region Skåne, Lund

All Listed Sponsors

collaborator

Lund University

OTHER

lead

Region Skane

OTHER